By Devika Patel
Knoxville, Tenn., Nov. 12 - Endocare, Inc. offered more details on a $16.25 million private placement of stock in an 8-K filed Wednesday with the Securities and Exchange Commission.
The financing, which priced Nov. 10, will close after the company's completed merger with Galil Medical Ltd., which is expected to settle in the first quarter of 2009.
The company will sell 16.25 million common shares at $1.00 per share.
Located in Irvine, Calif., Endocare develops minimally invasive medical devices used for tissue and tumor ablation.
| Issuer: | Endocare, Inc.
|
| Issue: | Common stock
|
| Amount: | $16.25 million
|
| Shares: | 16.25 million
|
| Price: | $1.00
|
| Warrants: | No
|
| Pricing date: | Nov. 10
|
| Stock symbol: | OTCBB: ENDO
|
| Stock price: | $0.96 at close Nov. 10
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
